BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ronkainen J, Talley NJ, Storskrubb T, Johansson SE, Lind T, Vieth M, Agréus L, Aro P. Erosive esophagitis is a risk factor for Barrett's esophagus: a community-based endoscopic follow-up study. Am J Gastroenterol 2011;106:1946-52. [PMID: 21946284 DOI: 10.1038/ajg.2011.326] [Cited by in Crossref: 63] [Cited by in F6Publishing: 46] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Lee SP, Sung I, Kim JH, Lee S, Park HS, Shim CS. The Clinical Features and Predisposing Factors of Asymptomatic Erosive Esophagitis. Dig Dis Sci 2016;61:3522-9. [DOI: 10.1007/s10620-016-4341-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
2 Ren D, Zheng G, Bream S, Tevebaugh W, Shaheen NJ, Chen X. Single nucleotide polymorphisms of caudal type homeobox 1 and 2 are associated with Barrett's esophagus. Dig Dis Sci 2014;59:57-63. [PMID: 23918153 DOI: 10.1007/s10620-013-2804-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
3 Bennett C, Vakil N, Bergman J, Harrison R, Odze R, Vieth M, Sanders S, Gay L, Pech O, Longcroft-Wheaton G, Romero Y, Inadomi J, Tack J, Corley DA, Manner H, Green S, Al Dulaimi D, Ali H, Allum B, Anderson M, Curtis H, Falk G, Fennerty MB, Fullarton G, Krishnadath K, Meltzer SJ, Armstrong D, Ganz R, Cengia G, Going JJ, Goldblum J, Gordon C, Grabsch H, Haigh C, Hongo M, Johnston D, Forbes-Young R, Kay E, Kaye P, Lerut T, Lovat LB, Lundell L, Mairs P, Shimoda T, Spechler S, Sontag S, Malfertheiner P, Murray I, Nanji M, Poller D, Ragunath K, Regula J, Cestari R, Shepherd N, Singh R, Stein HJ, Talley NJ, Galmiche JP, Tham TC, Watson P, Yerian L, Rugge M, Rice TW, Hart J, Gittens S, Hewin D, Hochberger J, Kahrilas P, Preston S, Sampliner R, Sharma P, Stuart R, Wang K, Waxman I, Abley C, Loft D, Penman I, Shaheen NJ, Chak A, Davies G, Dunn L, Falck-Ytter Y, Decaestecker J, Bhandari P, Ell C, Griffin SM, Attwood S, Barr H, Allen J, Ferguson MK, Moayyedi P, Jankowski JA. Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology. 2012;143:336-346. [PMID: 22537613 DOI: 10.1053/j.gastro.2012.04.032] [Cited by in Crossref: 263] [Cited by in F6Publishing: 225] [Article Influence: 26.3] [Reference Citation Analysis]
4 Fuchs KH, DeMeester TR, Otte F, Broderick RC, Breithaupt W, Varga G, Musial F. Severity of GERD and disease progression. Dis Esophagus 2021:doab006. [PMID: 33575739 DOI: 10.1093/dote/doab006] [Reference Citation Analysis]
5 Hunt R, Armstrong D, Katelaris P, Afihene M, Bane A, Bhatia S, Chen MH, Choi MG, Melo AC, Fock KM, Ford A, Hongo M, Khan A, Lazebnik L, Lindberg G, Lizarzabal M, Myint T, Moraes-Filho JP, Salis G, Lin JT, Vaidya R, Abdo A, LeMair A; Review Team:. World Gastroenterology Organisation Global Guidelines: GERD Global Perspective on Gastroesophageal Reflux Disease. J Clin Gastroenterol. 2017;51:467-478. [PMID: 28591069 DOI: 10.1097/mcg.0000000000000854] [Cited by in Crossref: 56] [Cited by in F6Publishing: 25] [Article Influence: 18.7] [Reference Citation Analysis]
6 Richter JE, Rubenstein JH. Presentation and Epidemiology of Gastroesophageal Reflux Disease. Gastroenterology. 2018;154:267-276. [PMID: 28780072 DOI: 10.1053/j.gastro.2017.07.045] [Cited by in Crossref: 125] [Cited by in F6Publishing: 82] [Article Influence: 25.0] [Reference Citation Analysis]
7 Forssell L, Cnattingius S, Bottai M, Edstedt Bonamy AK, Lagergren J, Agréus L, Akre O. Increased risk of Barrett’s esophagus among individuals born preterm or small for gestational age. Clin Gastroenterol Hepatol. 2013;11:790-794. [PMID: 23376800 DOI: 10.1016/j.cgh.2013.01.024] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
8 Miwa H, Takeshima T, Iwasaki K, Hiroi S. Medical cost, incidence rate, and treatment status of gastroesophageal reflux disease in Japan: analysis of claims data. J Med Econ 2016;19:1049-55. [PMID: 27207316 DOI: 10.1080/13696998.2016.1192551] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
9 Vaezi MF, Brunton S, Mark Fendrick A, Howden CW, Atkinson C, Pelletier C, Jacob R, Spechler SJ. Patient journey in erosive oesophagitis: real-world perspectives from US physicians and patients. BMJ Open Gastroenterol 2022;9:e000941. [PMID: 35868653 DOI: 10.1136/bmjgast-2022-000941] [Reference Citation Analysis]
10 Mahfouz R, Barchuk A, Obeidat AE, Mansour MM, Hernandez D, Darweesh M, Aldiabat M, Al-Khateeb MH, Yusuf MH, Aljabiri Y. The Relationship Between Obstructive Sleep Apnea (OSA) and Gastroesophageal Reflux Disease (GERD) in Inpatient Settings: A Nationwide Study. Cureus 2022;14:e22810. [PMID: 35399477 DOI: 10.7759/cureus.22810] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 O'Connor A, O'Morain CA, Ford AC. Population screening and treatment of Helicobacter pylori infection. Nat Rev Gastroenterol Hepatol. 2017;14:230-240. [PMID: 28053340 DOI: 10.1038/nrgastro.2016.195] [Cited by in Crossref: 94] [Cited by in F6Publishing: 83] [Article Influence: 18.8] [Reference Citation Analysis]
12 Fukuda N, Ishimura N, Okada M, Izumi D, Mikami H, Okimoto E, Aimi M, Mishiro T, Oshima N, Ishihara S, Kinoshita Y. Mucosal breaks show same circumferential distribution in majority of patients with recurrent reflux esophagitis. Endosc Int Open 2017;5:E214-21. [PMID: 28317018 DOI: 10.1055/s-0043-102401] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
13 Roark R, Sydor M, Chatila AT, Umar S, Guerra R, Bilal M, Guturu P. Management of gastroesophageal reflux disease. Dis Mon 2020;66:100849. [PMID: 30798984 DOI: 10.1016/j.disamonth.2019.02.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
14 Ford AC, Forman D, Bailey AG, Axon AT, Moayyedi P. The natural history of gastro-oesophageal reflux symptoms in the community and its effects on survival: a longitudinal 10-year follow-up study. Aliment Pharmacol Ther 2013;37:323-31. [PMID: 23190336 DOI: 10.1111/apt.12169] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
15 Shah A, Shibli F, Kitayama Y, Fass R. The Natural Course of Gastroesophageal Reflux Disease: A Critical Appraisal of the Literature. J Clin Gastroenterol 2021;55:12-20. [PMID: 32909972 DOI: 10.1097/MCG.0000000000001419] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Smith CM, Michael MZ, Watson DI, Tan G, Astill DS, Hummel R, Hussey DJ. Impact of gastro-oesophageal reflux on microRNA expression, location and function. BMC Gastroenterol 2013;13:4. [PMID: 23297865 DOI: 10.1186/1471-230X-13-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
17 Gargus M, Niu C, Vallone JG, Binkley J, Rubin DC, Shaker A. Human esophageal myofibroblasts secrete proinflammatory cytokines in response to acid and Toll-like receptor 4 ligands. Am J Physiol Gastrointest Liver Physiol 2015;308:G904-23. [PMID: 25882613 DOI: 10.1152/ajpgi.00333.2014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
18 Wang R, Wang J, Hu S. Study on the relationship of depression, anxiety, lifestyle and eating habits with the severity of reflux esophagitis. BMC Gastroenterol 2021;21:127. [PMID: 33743601 DOI: 10.1186/s12876-021-01717-5] [Reference Citation Analysis]
19 Bi D, Katzka DA, Lavey CJ, Geno DM, Ravi K. Erosive Esophagitis Portends a Benign Clinical Course in the Majority of Patients. Dig Dis Sci 2020;65:3244-52. [PMID: 31907769 DOI: 10.1007/s10620-019-06027-1] [Reference Citation Analysis]
20 Na'amnih W, Katz R, Goren S, Ben-Tov A, Ziv-Baran T, Chodick G, Muhsen K. Correlates of gastroenterology health-services utilization among patients with gastroesophageal reflux disease: a large database analysis. Isr J Health Policy Res 2019;8:66. [PMID: 31429808 DOI: 10.1186/s13584-019-0335-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
21 Labenz J, Labenz C. Prävalenz und natürlicher Verlauf der gastroösophagealen Refluxkrankheit. Gastroenterologe 2016;11:102-9. [DOI: 10.1007/s11377-016-0045-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
22 Estores D, Velanovich V. Barrett esophagus: epidemiology, pathogenesis, diagnosis, and management. Curr Probl Surg. 2013;50:192-226. [PMID: 23601575 DOI: 10.1067/j.cpsurg.2013.01.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
23 Kang SH, Lim Y, Lee H, Kim J, Chi S, Min YW, Min BH, Lee JH, Son HJ, Ryu S, Rhee PL, Kim JJ. A Model for Predicting the Future Risk of Incident Erosive Esophagitis in an Asymptomatic Population Undergoing Regular Check-ups. Medicine (Baltimore) 2016;95:e2591. [PMID: 26825906 DOI: 10.1097/MD.0000000000002591] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
24 Bennett C, Moayyedi P, Corley DA, DeCaestecker J, Falck-Ytter Y, Falk G, Vakil N, Sanders S, Vieth M, Inadomi J. BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett’s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol. 2015;110:662-682; quiz 683. [PMID: 25869390 DOI: 10.1038/ajg.2015.55] [Cited by in Crossref: 80] [Cited by in F6Publishing: 67] [Article Influence: 11.4] [Reference Citation Analysis]
25 Kumar A C, Mubarak D. Classification of Early Stages of Esophageal Cancer Using Transfer Learning. IRBM 2021. [DOI: 10.1016/j.irbm.2021.10.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Amir I, Konikoff FM, Oppenheim M, Gophna U, Half EE. Gastric microbiota is altered in oesophagitis and Barrett's oesophagus and further modified by proton pump inhibitors. Environ Microbiol. 2014;16:2905-2914. [PMID: 24112768 DOI: 10.1111/1462-2920.12285] [Cited by in Crossref: 90] [Cited by in F6Publishing: 90] [Article Influence: 10.0] [Reference Citation Analysis]
27 Aro P, Ronkainen J. Evolution of GERD over 5 years. Aliment Pharmacol Ther 2012;35:393-4; discussion 395-6. [PMID: 22221083 DOI: 10.1111/j.1365-2036.2011.04943.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
28 Pinto D, Plieschnegger W, Schneider NI, Geppert M, Bordel H, Höss GM, Eherer A, Wolf E, Vieth M, Langner C. Carditis: a relevant marker of gastroesophageal reflux disease. Data from a prospective central European multicenter study on histological and endoscopic diagnosis of esophagitis (histoGERD trial). Diseases of the Esophagus 2018;32. [DOI: 10.1093/dote/doy073] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
29 Ness-Jensen E. Epidemiology and prevention of oesophageal adenocarcinoma. Scand J Gastroenterol 2022;:1-5. [PMID: 35234549 DOI: 10.1080/00365521.2022.2042594] [Reference Citation Analysis]
30 Baima DC, Carvalho NS, Barbuti RC, Navarro-Rodriguez T. ASSESSMENT OF THE INTESTINAL MICROBIOTA IN ADULTS WITH EROSIVE ESOPHAGITIS. Arq Gastroenterol 2021;58:168-74. [PMID: 34287529 DOI: 10.1590/S0004-2803.202100000-29] [Reference Citation Analysis]
31 Marques de Sá I, Marcos P, Sharma P, Dinis-Ribeiro M. The global prevalence of Barrett's esophagus: A systematic review of the published literature. United European Gastroenterol J 2020;8:1086-105. [PMID: 32631176 DOI: 10.1177/2050640620939376] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
32 Arora Z, Garber A, Thota PN. Risk factors for Barrett's esophagus. J Dig Dis 2016;17:215-21. [PMID: 26929263 DOI: 10.1111/1751-2980.12332] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
33 Westra WM, Lutzke LS, Mostafavi NS, Roes AL, Calpe S, Wang KK, Krishnadath KK. Smokeless Tobacco and Cigar and/or Pipe Are Risk Factors for Barrett Esophagus in Male Patients With Gastroesophageal Reflux Disease. Mayo Clinic Proceedings 2018;93:1282-9. [DOI: 10.1016/j.mayocp.2018.04.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Nevalainen P, Walamies M, Kruuna O, Arkkila P, Aaltonen L. Supragastric belch may be related to globus symptom - a prospective clinical study. Neurogastroenterol Motil 2016;28:680-6. [DOI: 10.1111/nmo.12764] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
35 Crews NR, Johnson ML, Schleck CD, Enders FT, Wongkeesong LM, Wang KK, Katzka DA, Iyer PG. Prevalence and Predictors of Gastroesophageal Reflux Complications in Community Subjects. Dig Dis Sci 2016;61:3221-8. [PMID: 27510751 DOI: 10.1007/s10620-016-4266-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
36 Peter S, Mönkemüller K. Ablative Endoscopic Therapies for Barrett’s-Esophagus-Related Neoplasia. Gastroenterology Clinics of North America 2015;44:337-53. [DOI: 10.1016/j.gtc.2015.02.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
37 Labenz J, Chandrasoma PT, Knapp LJ, DeMeester TR. Proposed approach to the challenging management of progressive gastroesophageal reflux disease. World J Gastrointest Endosc 2018; 10(9): 175-183 [PMID: 30283600 DOI: 10.4253/wjge.v10.i9.175] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 6] [Article Influence: 3.8] [Reference Citation Analysis]
38 Soucy G, Onstad L, Vaughan TL, Odze RD. Histologic Features Associated With Columnar-lined Esophagus in Distal Esophageal and Gastroesophageal Junction (GEJ) Biopsies From GERD Patients: A Community-based Population Study. Am J Surg Pathol 2016;40:827-35. [PMID: 26927889 DOI: 10.1097/PAS.0000000000000623] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
39 Splittgerber M, Velanovich V. Barrett esophagus. Surg Clin North Am 2015;95:593-604. [PMID: 25965132 DOI: 10.1016/j.suc.2015.02.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
40 Westra WM, Rygiel AM, Mostafavi N, de Wit GMJ, Roes AL, Moons LMG, Peppelenbosch MP, Ouburg S, Morré SA, Jacobs M, Siersema PD, Repping S, Wang KK, Krishnadath KK. The Y-chromosome F haplogroup contributes to the development of Barrett's esophagus-associated esophageal adenocarcinoma in a white male population. Dis Esophagus 2020;33:doaa011. [PMID: 32129453 DOI: 10.1093/dote/doaa011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Prichard DO, Byrne AM, Murphy JO, Reynolds JV, O'Sullivan J, Feighery R, Doyle B, Eldin OS, Finn SP, Maguire A, Duff D, Kelleher DP, Long A. Deoxycholic acid promotes development of gastroesophageal reflux disease and Barrett's oesophagus by modulating integrin-αv trafficking. J Cell Mol Med 2017;21:3612-25. [PMID: 28941013 DOI: 10.1111/jcmm.13271] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
42 Hung WC, Wu JS, Sun ZJ, Lu FH, Yang YC, Chang CJ. Gender differences in the association of non-alcoholic fatty liver disease and metabolic syndrome with erosive oesophagitis: a cross-sectional study in a Taiwanese population. BMJ Open 2016;6:e013106. [PMID: 27852719 DOI: 10.1136/bmjopen-2016-013106] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Chang CH, Wu CP, Wang JD, Lee SW, Chang CS, Yeh HZ, Ko CW, Lien HC. Alcohol and tea consumption are associated with asymptomatic erosive esophagitis in Taiwanese men. PLoS One. 2017;12:e0173230. [PMID: 28264069 DOI: 10.1371/journal.pone.0173230] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
44 Savarino E, de Bortoli N, De Cassan C, Della Coletta M, Bartolo O, Furnari M, Ottonello A, Marabotto E, Bodini G, Savarino V. The natural history of gastro-esophageal reflux disease: a comprehensive review. Dis Esophagus. 2017;30:1-9. [PMID: 27862680 DOI: 10.1111/dote.12511] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
45 Triadafilopoulos G, Friedland S. Precision care for Barrett's esophagus. Transl Gastroenterol Hepatol 2018;3:67. [PMID: 30363757 DOI: 10.21037/tgh.2018.09.10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
46 Rey JW, Deris N, Marquardt JU, Thomaidis T, Moehler M, Kittner JM, Nguyen-Tat M, Dümcke S, Tresch A, Biesterfeld S, Goetz M, Mudter J, Neurath MF, Galle PR, Kiesslich R, Hoffman A. High-definition endoscopy with iScan and Lugol's solution for the detection of inflammation in patients with nonerosive reflux disease: histologic evaluation in comparison with a control group. Dis Esophagus 2016;29:185-91. [PMID: 25515856 DOI: 10.1111/dote.12308] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
47 Leodolter A, Nocon M, Vieth M, Lind T, Jaspersen D, Richter K, Willich S, Stolte M, Malfertheiner P, Labenz J. Progression of specialized intestinal metaplasia at the cardia to macroscopically evident Barrett's esophagus: an entity of concern in the ProGERD study. Scand J Gastroenterol 2012;47:1429-35. [PMID: 23110405 DOI: 10.3109/00365521.2012.733952] [Cited by in Crossref: 36] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
48 Chih PC, Yang YC, Wu JS, Chang YF, Lu FH, Chang CJ. Overweight associated with increased risk of erosive esophagitis in a non-obese Taiwanese population. PLoS One 2013;8:e77932. [PMID: 24223746 DOI: 10.1371/journal.pone.0077932] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
49 Westra WM, Straub D, Milano F, Buttar NS, Wang KK, Krishnadath KK. Inhibition of the BMP pathway prevents development of Barrett's-associated adenocarcinoma in a surgical rat model. Dis Esophagus 2021:doab072. [PMID: 34718471 DOI: 10.1093/dote/doab072] [Reference Citation Analysis]
50 Naik RD, Vaezi MF. Recent advances in diagnostic testing for gastroesophageal reflux disease. Expert Rev Gastroenterol Hepatol 2017;11:531-7. [PMID: 28317452 DOI: 10.1080/17474124.2017.1309286] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
51 Katzka DA, Pandolfino JE, Kahrilas PJ. Phenotypes of Gastroesophageal Reflux Disease: Where Rome, Lyon, and Montreal Meet. Clin Gastroenterol Hepatol 2020;18:767-76. [PMID: 31319183 DOI: 10.1016/j.cgh.2019.07.015] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 15.7] [Reference Citation Analysis]
52 Nagahara A, Suzuki T, Nagata N, Sugai N, Takeuchi Y, Sakurai K, Miyamoto M, Inoue K, Akiyama J, Mabe K. A multicentre randomised trial to compare the efficacy of omeprazole versus rabeprazole in early symptom relief in patients with reflux esophagitis. J Gastroenterol. 2014;49:1536-1547. [PMID: 24366288 DOI: 10.1007/s00535-013-0925-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
53 Ronkainen J, Agréus L. Epidemiology of reflux symptoms and GORD. Best Pract Res Clin Gastroenterol 2013;27:325-37. [PMID: 23998972 DOI: 10.1016/j.bpg.2013.06.008] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]